Immune-based cancer treatment : the T lymphocyte response / Michael A. Alexander. — Boca Raton, FL : CRC Press ; Enfield, N.H. : Science Publishers, c2011. – (64.86/A377)

Contents

    Contents
    
    Foreword
    Acknowledgements
    Introduction
    1. Which Cells Control the Anti-cancer T cell Immune Response?
    2. Antigen Presentation
    3. T cells and Cancer Cells: Components of Immune-based Anti-cancer Therapy
    4. Anti-cancer Vaccines: New Approaches
    5. How and Why Do We Get Cancer and Can Immune-based Anti-cancer Therapy Save Us?
    6. Immunotherapeutic Approaches to the Treatment of Leukemia
    7. Cancer-induced Autoimmunity
    8. Can We Solve the Cancer Stem Cell Program and Cure Cancer Using T cell-based Immunotherapy?
    9. Translational Immunology and Its Impact on Anti-cancer T cell Immunity and the Development of Immunotherapeutic Treatments for Cancer
    10. Dendritic Cells， Immunotherapy and the Anti-cancer T cell Response
    11. Regulatory T cells， Dendritic cells and the Success of Immunotherapeutic Treatments for Cancer
    12. NK Cells and Their Role in the Development of Immune-based Anti-cancer Therapy
    13. How Cancer cells Influence the Anti-cancer T cell Immune Response and Why This Is a Problem during the Immunotherapeutic Treatment of Cancer
    14. The T cell Anti-cancer Response， T cell Regulation， and Immunotherapy of Neural Crest Cancers
    15. The Immunological Hole: Will We Fall In?
    16. Summary and Concluding Remarks
    References
    Index